癌症化疗进展：泌尿生殖系统癌症，第5部分：卵巢癌。
Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.
作者信息
Wright J C
出版信息
J Natl Med Assoc. 1988 May;80(5):565-76.
An update of the state of the art of cancer chemotherapeutic treatment of genitourinary tract cancer is described in this multi-part series: included are cancers of the kidney, bladder, prostate, testicle, ovary, uterus, vulva, and gestational trophoblastic neoplasms. Part 5 is a review of treatments for cancer of the ovary.Ovarian cancer is the leading cause of gynecologic cancer deaths and the fourth most frequent cause of death from cancer in women in the United States. Ovarian carcinoma is a classical "hidden" neoplasm of the abdomen and, as such, is insidious in its onset. Combination chemotherapy and cytoreductive surgery, however, have provided improved survival for patients with ovarian cancer. As dosage schedules and other refinements are made, the overall outlook for patients with ovarian cancer is promising.
本多部分系列文章介绍了泌尿生殖系统癌症化疗治疗的最新进展
包括肾癌、膀胱癌、前列腺癌、睾丸癌、卵巢癌、子宫癌、外阴癌以及妊娠滋养细胞肿瘤。第5部分是关于卵巢癌治疗的综述。卵巢癌是妇科癌症死亡的主要原因，在美国也是女性癌症死亡的第四大常见原因。卵巢癌是腹部典型的“隐匿性”肿瘤，因此其发病隐匿。然而，联合化疗和细胞减灭术已提高了卵巢癌患者的生存率。随着剂量方案和其他改进措施的实施，卵巢癌患者的总体前景很乐观。
Zotero 插件